$4.34 0.04 (+0.93%)
2/13/2012 10:09 AM

XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Featured Broker Partners


Advertisement